OVERVIEW

AHK-Cu (Copper Tripeptide-1) 200 mg (Topical) is a peptide complex widely used in skincare for its regenerative and healing properties. AHK-Cu combines the tripeptide sequence (alanine-histidine-lysine) with a copper ion, which enhances its biological activity. Copper plays a key role in skin repair, wound healing, and production of structural proteins such as collagen and elastin. When applied topically in formulations containing approximately 200 mg, AHK-Cu is marketed to support skin firmness, reduce the appearance of fine lines and wrinkles, promote even skin tone, and improve overall texture. Its mechanism involves acting as a signaling molecule that can stimulate fibroblast activity and support antioxidant defenses, making it a popular ingredient in anti-aging and skin renewal serums and creams.

Despite its widespread use in cosmetic products, AHK-Cu is classified as a cosmetic or cosmeceutical ingredient rather than a pharmaceutical drug. It is not formally approved by major regulatory bodies such as the U.S. Food and Drug Administration for treating medical conditions. Scientific studies on AHK-Cu show promising effects in cell-based and limited clinical settings, but robust evidence from large, peer-reviewed trials on long-term benefits and safety in diverse populations remains limited. Consumers should approach topical peptide products with realistic expectations, perform patch tests for sensitivity, and consult a qualified dermatologist for personalized skincare advice.